* Cross Country Healthcare Inc CCRN.OQ CCRN.O is
expected
to show a fall in quarterly revenue when it reports results
* The Boca Raton Florida-based company is expected to
report a
30.2% decrease in revenue to $443.903 million from $636.1
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. The company's guidance on
August 2 2023, for the period ended September 30, was for
revenue between 440.00 million and 450.00 million.
* Refinitiv's mean analyst estimate for Cross Country
Healthcare
Inc is for earnings of 41 cents per share. The company's EPS
guidance on August 2 2023, for the period ended September
30, was between 0.35 and 0.45
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cross
Country
Healthcare Inc is $29, above its last closing price of $23.02.
The company's guidance on August 2 2023 for the period ended
September 30 was for Earnings before Interest, Taxes,
Depreciation and Amortization of between 440 million and 32
million.The company's guidance on August 2 2023 for the period
ended September 30 was for gross profit margin between 22.5% and
23%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 0.61 0.61 0.69 Beat 13.3
Mar. 31 2023 0.75 0.75 0.84 Beat 12.4
Dec. 31 2022 0.89 0.89 1.09 Beat 21.9
Sep. 30 2022 0.96 0.95 1.07 Beat 12.6
Jun. 1.35 1.35 1.40 Beat 3.8
30 2022
Mar. 31 2022 1.34 1.31 1.70 Beat 29.3
Dec. 31 2021 1.30 1.24 1.40 Beat 12.6
Sep. 30 2021 0.34 0.34 0.61 Beat 77
This summary was machine generated October 30 at 20:12 GMT. All
figures in US dollars unless otherwise stated